Premium
Combination of intralesional verapamil and oral antioxidants for P eyronie's disease: a prospective, randomised controlled study
Author(s) -
Favilla V.,
Russo G. I.,
Privitera S.,
Castelli T.,
Madonia M.,
La Vignera S.,
Condorelli R.,
Calogero A. E.,
Farina F. P.,
Cimino S.,
Morgia G.
Publication year - 2014
Publication title -
andrologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.633
H-Index - 59
eISSN - 1439-0272
pISSN - 0303-4569
DOI - 10.1111/and.12178
Subject(s) - medicine , peyronie's disease , erectile function , verapamil , prospective cohort study , significant difference , urology , surgery , gastroenterology , erectile dysfunction , calcium
Summary The aim of this study was to evaluate the efficacy of the association of intralesional verapamil ( ILV ) injection with oral antioxidants compared with ILV monotherapy in patients with early onset of P eyronie's disease ( PD ) at 12‐week follow‐up. Group A ( n = 52) received ILV 10 mg weekly for 12 weeks, while group B ( n = 53) received ILV 10 mg weekly for 12 weeks + antioxidants orally one tablet once a day for 3 months. The main efficacy outcomes were the change in plaque size ( PS ), penile curvature ( PC ), visual analogue score ( VAS ), IIEF ‐15 and IIEF ‐15 subdomains. Both groups showed significant improvement from baseline to week 12 relative to PS and PC , while group B also in IIEF ‐15 score (mean difference: 5.51, P < 0.01) and VAS (mean difference: −2.71, P < 0.01). No significant differences were observed between both groups in PS and PC . Finally, both groups showed significant increase in orgasmic function ( IIEF ‐ OF ) and overall satisfaction ( IIEF ‐ OS ), while group B showed significant improvement also in intercourse satisfaction ( IIEF ‐ IS ). Significant differences were found relative to IIEF ‐ OF , IIEF ‐ IS , IIEF ‐ OS and VAS scores in the group B compared with group A. Patients affected by PD may benefit from combination treatment with ILV and oral antioxidants thanks to the improvement in IIEF ‐ OF , IIEF ‐ IS and IIEF ‐ OS at 12 weeks.